MarketPulse

Friedreich's ataxia

2 articles
BenzingaBenzinga··Globe Newswire

Larimar Therapeutics Raises $100M in Expanded Share Offering

Larimar Therapeutics raises $100M through expanded share offering at $5 per share, funding development of lead drug candidate nomlabofusp and operations.
LRMRpublic offeringcapital raise
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Larimar Therapeutics Raises $100M Through Expanded Public Offering

Larimar Therapeutics raises $100M through expanded public offering at $5 per share, funding clinical development of rare disease therapeutic candidate nomlabofusp.
LRMRclinical-stagepublic offering